IL90281A - Preparations containing MGI antibodies - Google Patents
Preparations containing MGI antibodiesInfo
- Publication number
- IL90281A IL90281A IL9028189A IL9028189A IL90281A IL 90281 A IL90281 A IL 90281A IL 9028189 A IL9028189 A IL 9028189A IL 9028189 A IL9028189 A IL 9028189A IL 90281 A IL90281 A IL 90281A
- Authority
- IL
- Israel
- Prior art keywords
- igm
- antibodies
- igg
- plasma
- derived
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Gram-negative bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20337788A | 1988-06-06 | 1988-06-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL90281A0 IL90281A0 (en) | 1989-12-15 |
| IL90281A true IL90281A (en) | 1994-10-07 |
Family
ID=22753737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL9028189A IL90281A (en) | 1988-06-06 | 1989-05-12 | Preparations containing MGI antibodies |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0345543B1 (de) |
| JP (1) | JP2703341B2 (de) |
| AT (1) | ATE112688T1 (de) |
| DE (1) | DE68918761T2 (de) |
| DK (1) | DK270389A (de) |
| ES (1) | ES2060695T3 (de) |
| IE (1) | IE64523B1 (de) |
| IL (1) | IL90281A (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3825429C2 (de) * | 1988-07-27 | 1994-02-10 | Biotest Pharma Gmbh | Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt |
| US5029840A (en) * | 1988-08-30 | 1991-07-09 | Ricoh Company, Ltd. | Automatic sheet feeder for an image recording apparatus |
| ATE211486T1 (de) * | 1995-09-22 | 2002-01-15 | Zlb Bioplasma Ag | Verfahren zur gewinnung von immunglobulinen aus fraktionen, die bei der fraktionierung von menschlichem blutplasma entstehen |
| JP4688457B2 (ja) * | 2004-09-10 | 2011-05-25 | 四国乳業株式会社 | 免疫増強組成物 |
| GB201006753D0 (en) | 2010-04-22 | 2010-06-09 | Biotest Ag | Process for preparing an immunolobulin composition |
| US10570194B2 (en) * | 2015-08-06 | 2020-02-25 | Grifols Worldwide Operations Limited | Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM) |
| US9913903B2 (en) | 2015-08-06 | 2018-03-13 | Grifols Worldwide Operations Limited | Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM |
| EP3275897A1 (de) | 2016-07-27 | 2018-01-31 | Biotest AG | Verfahren zur herstellung von immunoglobulinzusammensetzungen |
| CN112409477B (zh) * | 2019-08-21 | 2022-11-08 | 广东菲鹏生物有限公司 | IgM纯化方法 |
| KR20220166819A (ko) * | 2020-04-10 | 2022-12-19 | 바누디스 게엠베하 | 예방 및 치료에서의 천연 항체 |
| UY39318A (es) * | 2020-07-10 | 2022-02-25 | Grifols Worldwide Operations Ltd | Procedimiento para obtener una composicion que comprende inmunoglobulina m derivada de plasma humano |
| AU2024380406A1 (en) | 2023-11-15 | 2026-04-16 | Biotest Ag | Method of manufacturing an igm containing composition |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3597409A (en) * | 1970-05-25 | 1971-08-03 | American Cyanamid Co | Process for recoverring immunoglobulin a and immunoglobulin m |
| US3808189A (en) * | 1973-03-15 | 1974-04-30 | American Cyanamid Co | Isolation of gamma globulin preparations enriched in iga and igm using polyethylene glycol |
| US4604235A (en) * | 1984-05-23 | 1986-08-05 | J. T. Baker Chemical Company | Purification of monoclonal antibodies |
-
1989
- 1989-05-12 IL IL9028189A patent/IL90281A/en not_active IP Right Cessation
- 1989-05-24 ES ES89109372T patent/ES2060695T3/es not_active Expired - Lifetime
- 1989-05-24 DE DE68918761T patent/DE68918761T2/de not_active Expired - Fee Related
- 1989-05-24 EP EP89109372A patent/EP0345543B1/de not_active Expired - Lifetime
- 1989-05-24 AT AT89109372T patent/ATE112688T1/de not_active IP Right Cessation
- 1989-06-02 DK DK270389A patent/DK270389A/da unknown
- 1989-06-05 JP JP1141278A patent/JP2703341B2/ja not_active Expired - Lifetime
- 1989-06-12 IE IE180589A patent/IE64523B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IE891805L (en) | 1989-12-06 |
| EP0345543A3 (en) | 1990-06-13 |
| ES2060695T3 (es) | 1994-12-01 |
| EP0345543A2 (de) | 1989-12-13 |
| DK270389A (da) | 1989-12-07 |
| EP0345543B1 (de) | 1994-10-12 |
| ATE112688T1 (de) | 1994-10-15 |
| JP2703341B2 (ja) | 1998-01-26 |
| IE64523B1 (en) | 1995-08-09 |
| IL90281A0 (en) | 1989-12-15 |
| DK270389D0 (da) | 1989-06-02 |
| DE68918761T2 (de) | 1995-02-16 |
| JPH0267228A (ja) | 1990-03-07 |
| DE68918761D1 (de) | 1994-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1341505C (en) | Intravenously administered polyclonal immunoglobulin preparation containing igm and method of manufacture | |
| US7795402B2 (en) | Anti-Staphylococcus aureus antibodies | |
| JP2601551B2 (ja) | ウイルスを不活性化する方法 | |
| EP0345543B1 (de) | Therapeutische IgM-Konzentrate | |
| Baumgartner et al. | Controversies in the use of passive immunotherapy for bacterial infections in the critically ill patient | |
| US5252480A (en) | Human monoclonal antibody and hybridoma producing the same | |
| JP2730913B2 (ja) | 精製されたIgM | |
| Leigh et al. | Streptococcus uberis resists the bactericidal action of bovine neutrophils despite the presence of bound immunoglobulin | |
| Schiff | Intravenous gammaglobulin: pharmacology, clinical uses and mechanisms of action. | |
| Sawada et al. | Characterization of a human monoclonal antibody to lipopolysaccharides of Pseudomonas aeruginosa serotype 5: a possible candidate as an immunotherapeutic agent for infections with P. aeruginosa | |
| EP0441395B1 (de) | Humaner monoklonaler Antikörper und diesen enthaltende Arzneimittelzusammensetzung zur Behandlung von Pseudomonasinfektionen | |
| US5510465A (en) | Heat-treated IgM antibody preparations | |
| Hill et al. | Comparative protective activity of human monoclonal and hyperimmune polyclonal antibody against group B streptococci | |
| Rudner et al. | Systemic and topical protection studies using Pseudomonas aeruginosa flagella in an ocular model of infection | |
| Wordell | Use of intravenous immune globulin therapy: an overview | |
| US5157113A (en) | Removal of nucleic acids from monoclonal antibody preparations | |
| Bjornson et al. | Lack of a requirement for the Fc region of IgG in restoring pneumococcal opsonization via the alternative complement pathway in sickle cell disease | |
| JPH01197500A (ja) | ヒトモノクローナル抗体 | |
| US5324511A (en) | Vaccines and immunoglobulin G-containing preparations active against pseudomonas aeruginosa | |
| Shigeoka et al. | Monoclonal antibody preparations for immunotherapy of experimental GBS infection | |
| EP0368466B1 (de) | Zusammensetzungen und Methoden zur Behandlung und Vorbeugung von Gram-Negativen-Infektionen | |
| EP0383090A1 (de) | Menschlicher monoklonaler Antikörper gegen Pseudomonas Aeruginosa, Herstellung und Verwendung | |
| JPH0411897A (ja) | 抗緑膿菌外毒素aヒトモノクローナル抗体 | |
| WIKSTRÖM et al. | Production and characterization of monoclonal antibodies to Vibrio cholerae soluble haemagglutinin | |
| JPH04197195A (ja) | 緑膿薗リポ多糖に対するヒトモノクローナル抗体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| RH1 | Patent not in force |